Equetro - 30698-423-12 - (carbamazepine)

Alphabetical Index


Drug Information of Equetro

Product NDC: 30698-423
Proprietary Name: Equetro
Non Proprietary Name: carbamazepine
Active Ingredient(s): 300    mg/1 & nbsp;   carbamazepine
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Equetro

Product NDC: 30698-423
Labeler Name: Validus Pharmaceuticals LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021710
Marketing Category: NDA
Start Marketing Date: 20041210

Package Information of Equetro

Package NDC: 30698-423-12
Package Description: 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (30698-423-12)

NDC Information of Equetro

NDC Code 30698-423-12
Proprietary Name Equetro
Package Description 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (30698-423-12)
Product NDC 30698-423
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name carbamazepine
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20041210
Marketing Category Name NDA
Labeler Name Validus Pharmaceuticals LLC
Substance Name CARBAMAZEPINE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]

Complete Information of Equetro


General Information